Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
.
Show all posts
Showing posts with label
Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
.
Show all posts
Thursday, July 18, 2024
FDA Approves Wainua (eplontersen) for the Treatment of Adults with Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
›
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced the U.S. Food and Drug Administration (FDA) approval of Ionis and AstraZeneca's...
›
Home
View web version
